Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Helpful insights
View:
Post by biorun on Jan 04, 2022 1:47pm

Helpful insights

Here is a helpful commentary this am from Germany. 


M @ trix wrote on 04.01.22 18:34:46 post no.27.289 (70.393.621)
  In my opinion, the update shows that we are facing a decisive phase.  Both the potential pharmaceutical deal and antiviral test results are likely to have a MASSIVE impact on the course.  Both are probably only a few weeks away ("Completion of the final legal due diligence", "We expect results by the end of February 2022").  And - without wanting to tell me that - I think that the Top 10 Pharma have understood the possibilities of the technology (platform) from Sirona after this immensely long due diligence.  IF you license TFC-1067 I'm pretty sure it won't just stay that way.
 
  Because of the options: yes, a little "insensitive" just to bring this after "bad news" came in December about Wanbang.  However, options are just that: options.  They are only exercised if the course has developed significantly positively.  And it is also a kind of "payment".  Despite all the criticism, one should be fair enough and just see how LITTLE watered down Sirona in contrast to other biotech companies.  For example, I've had Redhill Biopharma, an Israeli biotech company, on my watchlist for many years.  They have been watering down on a huge scale for years.  Just google it: "Redhill Biopharma Offer".  So far they have hardly done anything with all that money.  Success can still come, but that's not the issue here.  I just want to say: 4 million options are, in my opinion, "peanuts".  MUCH more important is that they achieve the goals set.  And from my point of view absolutely positive things are priced into the nothing rating.
 
  After many months of waiting (and the high opportunity costs) everyone is annoyed and disappointed.  But: that is biotech.  Years of research can end up in vain (see TFC-039 / Wanbang).  But IF there is success, then it can go very quickly in completely different valuation ratios.  That’s why I’m here.  If you can't live with such a starting point, you shouldn't invest here or waste time with frustration postings.  It's just not rational.
 
  M @ trix
Comment by navajojoe on Jan 04, 2022 3:47pm
This post has been removed in accordance with Community Policy
Comment by jimmyhorizon on Jan 05, 2022 7:14pm
Thanks for picking this waxie. It shows very well what kind of mindset you serve here and why you are here and getting paid. Also thanks for the last two updates of 10/6/2021 and 1/4/2022. they were probably the most honest reports of the last 7 years. i also like to hear unpleasant truths. i like very much when you tell us that your dreamed milestones of the last two years went up in smoke ...more  
Comment by Tickel1st on Jan 05, 2022 7:57pm
This post has been removed in accordance with Community Policy
Comment by Tickel1st on Jan 05, 2022 7:58pm
This post has been removed in accordance with Community Policy
Comment by biorun on Jan 05, 2022 9:03pm
Lmfao I wish I was working for the man but they can't afford me. Can't blame an independent investor for trying to keep the conversation on topic and on the opportunity. It takes only a few moments a few times a day to set reason to all you infants sh!tting your diapers and whining like wet noodles.
Comment by navajojoe on Jan 06, 2022 8:47am
This post has been removed in accordance with Community Policy
Comment by Crazydan on Jan 06, 2022 9:03am
Biorun, look like it's time to change your pseudonym again!! Lmao
Comment by Tickel1st on Jan 06, 2022 12:29pm
This post has been removed in accordance with Community Policy
Comment by biorun on Jan 06, 2022 1:42pm
Thank you Tickle. Well said, and you accurately highlight the difference in perspectives, and I am ok with your views, when you are rational. You are here as I understand to get some real gains out of that original decision to buy shares. Well guess what, we share that in common. I have done my due diligence on Pullan, and while we should all be careful due to the past, she and her team brings ...more  
Comment by BurningMoney5 on Jan 06, 2022 3:01pm
thanks, Michelle!! Hope that you are right and maybe you sign some more NDA's next week at the exhibition.
Comment by biorun on Jan 06, 2022 5:23pm
I am not a she, you moron.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities